PT3027213T - Composições para melhorar e/ou prevenir efeitos colaterais adversos em antibioterapia - Google Patents
Composições para melhorar e/ou prevenir efeitos colaterais adversos em antibioterapiaInfo
- Publication number
- PT3027213T PT3027213T PT147555882T PT14755588T PT3027213T PT 3027213 T PT3027213 T PT 3027213T PT 147555882 T PT147555882 T PT 147555882T PT 14755588 T PT14755588 T PT 14755588T PT 3027213 T PT3027213 T PT 3027213T
- Authority
- PT
- Portugal
- Prior art keywords
- ameliorating
- compositions
- side effects
- adverse side
- antibiotic therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13003810.2A EP2832369A1 (en) | 2013-07-31 | 2013-07-31 | Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3027213T true PT3027213T (pt) | 2018-01-19 |
Family
ID=48914035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147555882T PT3027213T (pt) | 2013-07-31 | 2014-07-27 | Composições para melhorar e/ou prevenir efeitos colaterais adversos em antibioterapia |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP2832369A1 (pt) |
| DK (1) | DK3027213T3 (pt) |
| ES (1) | ES2655566T3 (pt) |
| NO (1) | NO3027213T3 (pt) |
| PL (1) | PL3027213T3 (pt) |
| PT (1) | PT3027213T (pt) |
| WO (1) | WO2015014470A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104705289B (zh) * | 2015-03-01 | 2016-08-24 | 安徽新生命干细胞科技有限公司 | 一种离体牙齿保存液 |
| EP3970713A1 (en) | 2020-09-16 | 2022-03-23 | GV Squared S.r.l. | Pharmaceutical composition comprising uridine and pyruvate for regulating the profileration, activity and survival of immune cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470838A (en) | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| US5633285A (en) * | 1991-03-01 | 1997-05-27 | Warner-Lambert Company | Cytoprotective wound healing compositions and methods for preparing and using same |
| US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
| US20070105782A1 (en) * | 2005-10-07 | 2007-05-10 | Board Of Trustees Of Southern Illinois University | Protectant Combinations for Reducing Toxicities |
| WO2013078554A1 (en) * | 2011-12-02 | 2013-06-06 | University Health Network | Compositions of tigecycline and uses thereof |
| US20150071904A1 (en) * | 2012-01-06 | 2015-03-12 | Trustees Of Boston University | Compositions and methods to boost endogenous ros production from bacteria |
-
2013
- 2013-07-31 EP EP13003810.2A patent/EP2832369A1/en not_active Withdrawn
-
2014
- 2014-07-27 NO NO14755588A patent/NO3027213T3/no unknown
- 2014-07-27 ES ES14755588.2T patent/ES2655566T3/es active Active
- 2014-07-27 PT PT147555882T patent/PT3027213T/pt unknown
- 2014-07-27 WO PCT/EP2014/002052 patent/WO2015014470A1/en active Application Filing
- 2014-07-27 DK DK14755588.2T patent/DK3027213T3/en active
- 2014-07-27 PL PL14755588T patent/PL3027213T3/pl unknown
- 2014-07-27 EP EP14755588.2A patent/EP3027213B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015014470A1 (en) | 2015-02-05 |
| DK3027213T3 (en) | 2018-01-15 |
| EP3027213A1 (en) | 2016-06-08 |
| EP3027213B1 (en) | 2017-10-18 |
| NO3027213T3 (pt) | 2018-03-17 |
| EP2832369A1 (en) | 2015-02-04 |
| ES2655566T3 (es) | 2018-02-20 |
| PL3027213T3 (pl) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226301A1 (zh) | 修飾的治療劑及其組合物 | |
| HK1217651A1 (zh) | 固溶體組合物及其在劇痛中的用途 | |
| IL286759A (en) | Therapeutic methods and preparations | |
| HK1216175A1 (zh) | 治療性化合物和組合物 | |
| GB201317286D0 (en) | Composition and Use | |
| HK1220920A1 (zh) | 治療性組合物和其用途 | |
| HK1217650A1 (zh) | 用於治療劇痛的組合物及方法 | |
| PL3057441T3 (pl) | Kompozycja do zapobiegania martwiczego zapalenia jelit u ptactwa z nadrzędu Galloanserae | |
| ZA201603240B (en) | Synergistic pesticidal compositions and related methods | |
| ZA201603225B (en) | Synergistic pesticidal compositions and related methods | |
| ZA201603228B (en) | Synergistic pesticidal compositions and related methods | |
| ZA201603235B (en) | Synergistic pesticidal compositions and related methods | |
| HK1222561A1 (zh) | 用於腫瘤學的組合物和方法 | |
| EP2968374A4 (en) | METHODS AND COMPOSITIONS FOR IMPROVING OXYGEN RATE IN FABRICS | |
| IL242584B (en) | An immunogenic preparation for use in treatment | |
| ZA201603224B (en) | Synergistic pesticidal compositions and related methods | |
| PT3027213T (pt) | Composições para melhorar e/ou prevenir efeitos colaterais adversos em antibioterapia | |
| ZA201603234B (en) | Synergistic pesticidal compositions and related methods | |
| GB201308753D0 (en) | Compounds and their use in therapy | |
| IL243091B (en) | Compositions and methods for use in oncology | |
| ZA201508585B (en) | Immunogenic composition for use in therapy | |
| GB201304675D0 (en) | Novel compositions having use in therapy | |
| GB201319255D0 (en) | Therapeutic compositions and methods | |
| GB201314623D0 (en) | Novel mucinase for use in therapy or prophylaxis | |
| GB201308217D0 (en) | Compounds and their use in therapy |